New drug combo shows promise for tough lung cancer
Disease control
Completed
This study tested a combination of two drugs (anlotinib and penpulimab) in 65 people with small cell lung cancer whose disease had worsened after initial chemotherapy. The goal was to see if the combination could shrink tumors and help people live longer. The approach aims to con…
Phase: PHASE2 • Sponsor: Hunan Cancer Hospital • Aim: Disease control
Last updated May 11, 2026 20:39 UTC